Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010790
Filing Date
2025-05-15
Accepted
2025-05-15 15:35:22
Documents
66
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 943012
2 EX-4.6 ex4-6.htm EX-4.6 96387
3 EX-10.2 ex10-2.htm EX-10.2 342232
4 EX-31.1 ex31-1.htm EX-31.1 21489
5 EX-31.2 ex31-2.htm EX-31.2 20919
6 EX-32.1 ex32-1.htm EX-32.1 7116
7 EX-32.2 ex32-2.htm EX-32.2 6551
8 GRAPHIC form10-q_001.jpg GRAPHIC 130597
9 GRAPHIC form10-q_002.jpg GRAPHIC 232087
10 GRAPHIC form10-q_003.jpg GRAPHIC 59541
11 GRAPHIC form10-q_004.jpg GRAPHIC 70010
12 GRAPHIC form10-q_005.jpg GRAPHIC 54607
13 GRAPHIC form10-q_006.jpg GRAPHIC 45007
  Complete submission text file 0001641172-25-010790.txt   7106672

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE gtbp-20250331.xsd EX-101.SCH 38979
15 XBRL CALCULATION FILE gtbp-20250331_cal.xml EX-101.CAL 32260
16 XBRL DEFINITION FILE gtbp-20250331_def.xml EX-101.DEF 166929
17 XBRL LABEL FILE gtbp-20250331_lab.xml EX-101.LAB 305622
18 XBRL PRESENTATION FILE gtbp-20250331_pre.xml EX-101.PRE 246678
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 778804
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 25952007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)